O-GalNAc glycosylation affects the immunogenicity of the receptor-binding domain (RBD) of SARS-CoV-2 spike protein.
Chem Commun (Camb)
; 59(13): 1797-1800, 2023 Feb 09.
Article
in En
| MEDLINE
| ID: mdl-36722411
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Viral Vaccines
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Chem Commun (Camb)
Journal subject:
QUIMICA
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
United kingdom